VivoSeq
Other

Pelvic Pain

0

Pipeline Programs↗

3

Active Trials↗

1

Companies Involved↗

Pelvic Pain is an early-stage landscape with 0 programs across 1 company. The most active players are S&R Farmaceutici S.p.A..

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

71/100

Attrition Rate

18/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

S

S&R Farmaceutici S.p.A.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

11

clinical trials

Completed5 · 45%
Terminated2 · 18%
Recruiting2 · 18%
Not yet recruiting1 · 9%
Unknown status1 · 9%

Clinical Trials

Trial Activity

11 trials

The Mechanisms Underlying Endometriosis Pain
Recruiting·WWashington University School of Medicine·N/A·NCT06101303·120 enrolled
Clinical Evaluation of the Efficacy and Safety of a Medical Device in the Form of Rectal Suppositories (Prospidol®) for the Treatment of Symptoms Associated With Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Recruiting·SS&R Farmaceutici S.p.A.·Preclinical·NCT07685847·40 enrolled
CT-guided Pudendal Nerve Cryoneurolysis for Palliation of Malignancy-induced Pelvic Pain
Not yet recruiting·UUniversity of Arizona·N/A·NCT06110065·15 enrolled
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
Completed·DDuramed Research·Phase 2·NCT00196313·95 enrolled
Effect of Melatonin on Reduction of Pelvic Pain
Completed·KKarolinska Institutet·Phase 2·NCT03782740·80 enrolled
Vaginal Diazepam for the Treatment of Female Pelvic Pain
Completed·—·Phase 2·NCT01938092·50 enrolled
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
Completed·DDuramed Research·Phase 3·NCT00196365·97 enrolled
Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction
Completed·NNorthwestern University·Phase 1·NCT03167216·20 enrolled
Botox as a Treatment for Chronic Male Pelvic Pain Syndrome
Terminated·UUniversity of Washington·Phase 4·NCT00194623·30 enrolled
Magnesium-Based Trigger Point Injections for Relief of Chronic Myofascial Pelvic Pain
Terminated·QQueen's University·Phase 3·NCT02728037·38 enrolled
Patient Reported Outcomes Following Interventional Procedures in Pelvic Pain
Unknown status·—·N/A·NCT05531500·60 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)